MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that through its subsidiary UG, it has received full occupancy at the state-of-the-art Duncan Facility located near Vancouver, British Columbia, Canada. UG was issued an Occupancy Permit as expected on 2 November 2015 after provincial and municipal review and approval.
Traditional Therapy Clinics Limited (ASX:TTC) has entered into contracts to acquire four clinics from its franchised clinic base in line with its business strategy to grow its owned clinic network and diversify its revenue stream.
MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or the "Company") today announces its activities report for the quarter ended 30 September 2015. Focus shifted to execution after successful post-merger integration; strong start to December quarter with unexpected developments positioning the Company well.
MMJ PhytoTech Limited's (ASX:MMJ) Management and Board are pleased to announce the commencement of the Phase 1 Clinical Trials being undertaken in Israel. A summary of the Phase 1 Clinical Trial was released to the market on July 6, 2015.
MMJ PhytoTech Limited (ASX:MMJ) advises that APP Securities Pty Ltd has issued an updated research report which is available on the Company's website.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to announce that it is accelerating its strategy to enter the Australian Medical Cannabis market, following the indicated regulatory reform by the Federal Government to legalise the use of cannabis for medical purposes and establish a licensed growing program to provide a safe and local source.
MMJ PhytoTech Limited (ASX:MMJ) ("MMJ" or the "Company") is pleased to provide investors with an update on the progress at its Duncan facility in Canada.
